+ All Categories
Home > Documents > Introduction to Pharmacovigilance (1)

Introduction to Pharmacovigilance (1)

Date post: 11-Apr-2017
Category:
Upload: mohamed-fouad
View: 287 times
Download: 1 times
Share this document with a friend
27
INTRODUCTION TO PHARMACOVIGILANCE Mohamed Fouad Qualified Person for Pharmacovigilance (QPPV) AUG Pharma
Transcript
Page 1: Introduction to Pharmacovigilance (1)

INTRODUCTION TO PHARMACOVIGILANCE

Mohamed FouadQualified Person for Pharmacovigilance (QPPV)AUG Pharma

Page 2: Introduction to Pharmacovigilance (1)

Medicines are safe (X)Approved medicines are safe (X)No medicine is safe (X)No medicine is without a risk ()

Benefit Risk Balance of medications

Page 3: Introduction to Pharmacovigilance (1)

There must be always a side effects

Page 4: Introduction to Pharmacovigilance (1)

WHAT IS PHARMACOVIGILANCE

Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problems

Page 5: Introduction to Pharmacovigilance (1)

LEARNING FROM HISTORY

Thalidomide disaster

Tranquillizer launched 1957 1st reports of birth defects 1961 10000 infants affected by

Phocomelia No teratogenicity detected during

clinical trials and prior to launch.

Page 6: Introduction to Pharmacovigilance (1)

Phocomelia 15 % Death rate

Page 7: Introduction to Pharmacovigilance (1)
Page 8: Introduction to Pharmacovigilance (1)

Kelsey received the President's Award for Distinguished Federal Civilian Service from President John F. Kennedy, 1962

FDA refused to authorize Thalidomide because of lack of safety data

Page 9: Introduction to Pharmacovigilance (1)

SAFETY IN DRUG DEVELOPMENT

drug industry

efficacy

Safety

Quality

Page 10: Introduction to Pharmacovigilance (1)

CLINICAL DEVELOPMENT OF MEDICINES

Page 11: Introduction to Pharmacovigilance (1)

Animal studies

• Acute toxicity• Chronic toxicity• Carcinogenicity• Reproductive

toxicity• Mutagenicity• Teratogenicity

Page 12: Introduction to Pharmacovigilance (1)

Clinical trials

Page 13: Introduction to Pharmacovigilance (1)
Page 14: Introduction to Pharmacovigilance (1)
Page 15: Introduction to Pharmacovigilance (1)
Page 16: Introduction to Pharmacovigilance (1)
Page 17: Introduction to Pharmacovigilance (1)

The need for Pharmacovigilance

1. Humanitarian concern2. Safe use of medicines3. ADRs are expensive4. Promoting rational use of medicines5. Ensuring public confidence6. Ethical concern

Page 18: Introduction to Pharmacovigilance (1)

Humanitarian concern

Hippocratic Oath: First Do No Harm

Page 19: Introduction to Pharmacovigilance (1)

Economical concern

• 4th – 6th cause of death• 5% hospital admissions• Occurs in 11% patients• Double cost/length of stay• Double mortality rate• 50% potential preventable• Less than 1% reported

ADRS US study

Page 20: Introduction to Pharmacovigilance (1)

WHO program for Pharmacovigilance

Page 21: Introduction to Pharmacovigilance (1)

Active ICSRs in the WHO Global ICSR database per million inhabitants and year

Page 22: Introduction to Pharmacovigilance (1)

Country distribution in WHO Global ICSR database

Page 23: Introduction to Pharmacovigilance (1)

Growth of the WHO Global ICSR database since its inception

Page 25: Introduction to Pharmacovigilance (1)

Pharmacovigilance Process

Page 26: Introduction to Pharmacovigilance (1)

Safety data communication

Page 27: Introduction to Pharmacovigilance (1)

Thank You


Recommended